Biology
Molecular Mechanisms of Antibiotic Resistance in Gram-Negative Bacteria
Quick fact
Gram-negative bacteria are intrinsically resistant to many antibiotics because their outer membrane acts as a formidable barrier, and they possess multidrug efflux pumps that actively expel a wide range of drugs.
Why this is interesting
Every year, millions of infections become harder to treat because of bacteria that are literally pumping antibiotics out or destroying them before they act. Why are Gram-negative bacteria so much tougher than Gram-positive ones?
Read the full explanation
Understanding Molecular Mechanisms of Antibiotic Resistance in Gram-Negative Bacteria
Imagine you're trying to break into a fortress. Gram-negative bacteria have two walls: an inner cell membrane and an outer membrane. The outer membrane is unique—it has a lipid bilayer with lipopolysaccharides on the surface and porins (pores) that allow only small molecules to pass. This outer barrier already blocks many antibiotics. Additionally, bacteria have tiny pumps (efflux pumps) embedded in their membranes that actively spit out toxic molecules, including antibiotics, before they can reach their targets. So even if an antibiotic gets through the outer membrane, the efflux pumps can eject it. This is why Gram-negative infections are often treated with a combination of antibiotics and why resistance is so challenging.
A deeper explanation
The major molecular mechanisms of antibiotic resistance in Gram-negatives fall into four categories: (1) enzymatic degradation or modification—for example, β-lactamases (like extended-spectrum β-lactamases and carbapenemases) that hydrolyze penicillins, cephalosporins, and carbapenems; aminoglycoside-modifying enzymes that add chemical groups to inactivate the drug; and enzymes that modify other antibiotic classes; (2) target site modification—mutations or enzymes that alter the drug's binding site so it can no longer inhibit—for instance, changes in ribosomal proteins or RNA, or methylation of the 16S rRNA that prevents aminoglycoside binding; (3) reduced permeability—downregulation of porin proteins (e.g., OmpF/OmpC) reduces antibiotic entry; (4) active efflux—overexpression of efflux pumps (e.g., AcrAB-TolC in E. coli) that remove multiple antibiotic classes from the periplasm and cytoplasm. These mechanisms are often encoded on plasmids or transposons, enabling rapid spread between bacteria via horizontal gene transfer. Understanding these mechanisms is crucial for developing new drugs and for designing combination therapies, as well as for guiding antibiotic stewardship to slow the emergence of resistance.